Randomized controlled trial evaluating synbiotic supplementation as an adjuvant therapy in the treatment of Parkinson’s disease

Authors

Institutions

Publication Details

Journal
Inflammopharmacology
Published
2025-05-28
DOI
https://doi.org/10.1007/s10787-025-01752-8
Citations
7
Primary Topic
Parkinson's Disease Mechanisms and Treatments
Type
article
Field-Weighted Citation Impact
9.72

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Randomized controlled trial evaluating synbiotic supplementation as an adjuvant therapy in the treatment of Parkinson’s disease

Dalia El‐Afify, Tarek M. Mostafa, Mohamed E Ramadan, Azza A. Ghali
7 citations
Inflammopharmacology
Parkinson's Disease Mechanisms and Treatments
9.72
article

Randomized controlled trial evaluating synbiotic supplementation as an adjuvant therapy in the treatment of Parkinson’s disease

Dalia El‐Afify, Tarek M. Mostafa, Mohamed E Ramadan, Azza A. Ghali
article en
7 citations

Abstract

No abstract available for this paper.
InflammopharmacologyVol. 33(7)
Tanta University (EG)
Tanta University
Good health and well-being
Openalex Percentile: Top 2%
Parkinson's Disease Mechanisms and Treatments
9.72
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Randomized controlled trial evaluating synbiotic supplementation as an adjuvant therapy in the treatment of Parkinson’s disease — Dalia El‐Afify, Tarek M. Mostafa, et al. · Inflammopharmacology (2025) | TGRS Research Map | TGRS